Posted by Millie Nelson, Editor, Partnering and Investment, BioXconomy on 28 January 2026
Merck reportedly in talks to buy Revolution in huge $28–32bn deal
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Life Science Partnering, Investment & Strategy